Department of Cardiovascular Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
3 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
A retrospective nomogram development and validation study in a single centre with good discrimination metrics (AUROC 0.901) and internal validation, but based on a surrogate endpoint (elevated troponin) rather than hard clinical outcomes, limiting generalizability.
A systematic review synthesizing medicinal chemistry advances in quinoline derivatives for cancer therapy, providing design insights and identifying challenges rather than reporting primary clinical or preclinical data.
Observational study with target trial emulation found no significant association between amino acid therapy and AKI, though hypothesis-generating subgroup signal in older patients.